J.A. McCubrey; N.M. Davis; S.L. Abramsa; G. Montalto; M. Cervello; M. Libra; F. Nicoletti; A.B. D’Assoro; L. Cocco; A.M. Martelli; L.S. Steelman., Targeting breast cancer initiating cells: advances in breast cancer research and therapy., «ADVANCES IN BIOLOGICAL REGULATION», 2014, 56, pp. 81 - 107 [Scientific article]
Clissa C;Finelli C;Follo MY; Stanzani M; Curti A; Paolini S;
Papayannidis C; Mongiorgi S; Parisi S; Abbenante MC; Bosi C;
Manzoli L; Martinelli G; Cocco L; Cavo M, AZACITIDINE IN HIGH AND LOW RISK MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE
EVALUATION OF 57 PATIENTS TREATED WITH 4 DIFFERENT THERAPEUTIC REGIMENS, in: HAEMATOLOGICA, «HAEMATOLOGICA», 2013, 98, pp. 200 - 200 (atti di: 44° Congress of the Italian Society of Hematology, VERONA, 20-23 OTTOBRE 2013) [Contribution to conference proceedings]
Follo MY; Clissa C; Mongiorgi S; Stoyanova M; Paolini S; Quaranta
M; Stanzani M; Martinelli G; Manzoli L; Cocco L; Finelli C, CLONAL ACTIVATION OF AKT IN LOW-RISK MDS PATIENTS WITH DEL(5Q) TREATED WITH LENALIDOMIDE, in: HAEMATOLOGICA, «HAEMATOLOGICA», 2013, 98, pp. 40 - 40 (atti di: 44° Congress of the Italian Society of Hematology, Verona, 20-23 OTTOBRE 2013) [Contribution to conference proceedings]
M.Y. Follo; S. Mongiorgi; C. Clissa; M. Stoyanova; S. Paolini; M. Quaranta; G. Martinelli; L. Manzoli; C. Cocco; C. Finelli, Clonal activation of Akt in low-risk MDS patients with del(5q) treated with lenalidomide, in: LEUKEMIA RESEARCH, «LEUKEMIA RESEARCH», 2013, 37, pp. S28 - S28 (atti di: 12th International Symposium on Myelodysplastic Syndromes (MDS), BERLIN, 8-11 MAGGIO 2013) [Contribution to conference proceedings]
Matilde Y Follo; Carlo Finelli; Cristina Clissa; Sara Mongiorgi; Carmen Baldazzi; Marta Stanzani; Michele Baccarani; Lucio Cocco, Clonal Effect Of Lenalidomide On Akt Activation In Low-Risk MDS Patients With Del(5q), in: BLOOD, «BLOOD», 2013, 122, pp. 5227 - 5227 (atti di: 55th ASH Annual Meeting and Exposition, NEW ORLEANS, 7-10 DICEMBRE 2013) [Contribution to conference proceedings]
Valeria Santini; Ari Melnick; Jaroslaw P. Maciejewski; Estelle Duprez;Clara Nervi; Lucio Cocco; Kevin G. Ford; Ghulam Mufti, Epigenetics in focus: Pathogenesis of myelodysplastic syndromes and the role of hypomethylating agents, «CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY», 2013, 88, pp. 231 - 245 [Scientific article]
Mariani GA; Maroni L; Bianchi L; Broccoli A; Lazzarini E; Marchegiani G; Mazzotti A; Mazzotti MC; Billi AM; Piccari GG; Cocco L; Manzoli L., Hepato-gastric and spleno-mesenteric arterial trunks: anatomical variation report and review of literature, «ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY», 2013, 118, pp. 217 - 222 [Scientific article]
W.H. Chappell; S.L. Abrams; K.M. Stadelman; M.M. LaHair; R.A. Franklin; L. Cocco; C. Evangelisti; F. Chiarini; A.M. Martelli; L.S. Steelman; J.A. McCubrey., Increased NGAL (Lnc2) expression after chemotherapeutic drug treatment., «ADVANCES IN BIOLOGICAL REGULATION», 2013, 53, pp. 146 - 155 [Scientific article]
Alessandro Poli; Irene Faenza; Francesca Chiarini; Alessandro Matteucci; James A. McCubrey; Lucio Cocco, K562 cell proliferation is modulated by PLCβ1 through a PKCα-mediated pathway, «CELL CYCLE», 2013, 12, pp. 1713 - 1721 [Scientific article]
J.A. McCubrey; L.S. Steelman; W.H. Chappell; S.L. Abrams; R.A. Franklin; G. Montalto; M. Cervello; F. Nicoletti; G. Malaponte; C. Massarino; M. Libra; J. Bäsecke; A. Tafuri; M. Milella; F. Chiarini; C. Evangelisti; L. Cocco; A.M. Martelli., New agents and approaches for targeting the RAS/RAF/MEK/ERK and PI3K/AKT/mTOR cell survival pathways., in: Cell Death Signaling in Cancer Biology and Treatment, NEW YORK CITY, Humana Press, 2013, pp. 331 - 372 [Chapter or essay]
Faenza I; Fiume R; Piazzi M; Colantoni A; Cocco L., Nuclear inositide specific phospholipase C signalling - interactions and activity, «THE FEBS JOURNAL», 2013, 280, pp. 6311 - 6321 [Scientific article]
Follo MY; Marmiroli S; Faenza I; Fiume R; Ramazzotti G; Martelli AM; Gobbi P; McCubrey JA; Finelli C; Manzoli FA; Cocco L, Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS, «ADVANCES IN BIOLOGICAL REGULATION», 2013, 53, pp. 2 - 7 [Scientific article]
M. Piazzi; W. L. Blalock; A. Bavelloni; I. Faenza; A. D'Angelo; N. M. Maraldi; L. Cocco, Phosphoinositide-specific Phospholipase C β 1b (PI-PLCβ1b) Interactome: Affinity Purification-Mass Spectrometry Analysis of PI-PLCβ1b with Nuclear Protein, «MOLECULAR & CELLULAR PROTEOMICS», 2013, 12, pp. 2220 - 2235 [Scientific article]
Follo MY; Malagola M; Filì C; Finelli C; Iacobucci I; Martinelli G;
Cattina F; Clissa C;Candoni A; Fanin R; Gobbi M; Bocchia M;
Defina M; Spedini P; Skert C; Manzoli L; Cocco L; Russo D, PI-PLCBETA1 GENE METHYLATION AND EXPRESSION AS A RELIABLE AND DYNAMIC
MARKER OF CLINICAL RESPONSE TO 5-AZACYTIDINE IN PATIENTS WITH LOW-RISK MYELODYSPLASTIC SYNDROMES, in: HAEMATOLOGICA, «HAEMATOLOGICA», 2013, 98, pp. 196 - 196 (atti di: 44° Congress of the Italian Society of Hematology, VERONA, 20-23 OTTOBRE 2013) [Contribution to conference proceedings]
Filì C; Malagola M; Follo MY; Finelli C; Iacobucci I; Martinelli G; Cattina F; Clissa C; Candoni A; Fanin R; Gobbi M; Bocchia M; Defina M; Spedini P; Skert C; Manzoli L; Cocco L; Russo D., Prospective phase II Study on 5-days azacitidine for treatment of symptomatic and/or erythropoietin unresponsive patients with low/INT-1-risk myelodysplastic syndromes, «CLINICAL CANCER RESEARCH», 2013, 19, pp. 3297 - 3308 [Scientific article]
